Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclophosphamide hypersensitivity in a leukemic child.

Miguel A Rosas-Vargas1, Begonia Casas-Becerra, Yadira Velázquez-Armenta

  • 1Department of Allergy and Immunology, Hospital Infantil de México Federico Gómez, México DF 06720, México.

Therapeutic Drug Monitoring
|May 21, 2005
PubMed
Summary

Hypersensitivity reactions to cyclophosphamide (CPM) are rare but can occur during chemotherapy. This case demonstrates successful desensitization to CPM in a pediatric patient with acute lymphoblastic leukemia, enabling treatment completion.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe Asthma Patients' Characteristics in Mexico Versus International Severe Asthma Registry (ISAR) Global.

Current allergy and asthma reports·2026
Same author

[MIA 2.0, Comprehensive asthma management, guidelines for Mexico].

Boletin medico del Hospital Infantil de Mexico·2025
Same author

Frequency of hand contact with hospital surfaces in hospitalized pediatric patients.

Boletin medico del Hospital Infantil de Mexico·2024
Same author

A dysregulated bile acids pool is associated with metabolic syndrome and gut microbial dysbiosis in early adolescence.

Obesity (Silver Spring, Md.)·2023
Same author

[Guidelines on atopic dermatitis for Mexico (GUIDAMEX): using the ADAPTE methodology].

Gaceta medica de Mexico·2023
Same author

An independent in-depth analysis proposing adjusted Global Initiative on Asthma Step 1-2 treatment suggestions.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2021

Area of Science:

  • Oncology
  • Pharmacology
  • Allergy and Immunology

Background:

  • Hypersensitivity reactions to chemotherapeutic agents, though infrequent, can complicate cancer treatment.
  • Cyclophosphamide (CPM) is a widely used chemotherapeutic agent for various cancers, including acute lymphoblastic leukemia (ALL).
  • Adverse drug reactions (ADRs) to chemotherapy necessitate careful management to ensure treatment continuity.

Purpose of the Study:

  • To report a case of hypersensitivity reaction to cyclophosphamide in a pediatric patient with relapsed ALL.
  • To describe the successful desensitization protocol for cyclophosphamide-induced hypersensitivity.
  • To highlight the feasibility of continuing essential chemotherapy despite severe drug reactions.

Main Methods:

  • A 13-year-old boy with ALL experienced a hypersensitivity reaction after the fourth cycle of intravenous cyclophosphamide.

Related Experiment Videos

  • Standard allergy testing for cyclophosphamide hypersensitivity was negative.
  • A desensitization procedure was performed prior to subsequent chemotherapy cycles.

    • Main Results:

    • The patient developed symptoms including rash, sweating, respiratory distress, and anxiety following cyclophosphamide administration.
    • Despite negative skin tests, a second reaction confirmed hypersensitivity to cyclophosphamide.
    • Successful desensitization allowed the patient to complete all 12 planned cycles of chemotherapy without recurrence of hypersensitivity symptoms.

    Conclusions:

    • Successful desensitization to cyclophosphamide is a viable option for patients experiencing hypersensitivity reactions.
    • This approach enables the continuation of critical chemotherapy regimens, improving patient outcomes.
    • Management of chemotherapy-induced hypersensitivity reactions can be achieved through specialized desensitization protocols.